AnswerList | APOE Interpretations | LL6026-0 |
LONG_COMMON_NAME | en-US | The E2/E3 combination of ApoE isoforms is considered lower risk with a 0.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). |
LOINC Version: 2.77